| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Deficiency Does Not Alter Insulin Sensitivity in Mice Maintained on Regular or High-Fat Diet: Hyperinsulinemic-Euglycemic Clamp Studies
Third Department of Medicine (M.H.), First Faculty of Medicine, Charles University, 128 08 Prague 2, Czech Republic; and Mouse Metabolism Laboratory (O.G.) and Diabetes Branch (D.L.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1758
Address all correspondence and requests for reprints to: Martin Haluzik, Third Department of Medicine, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08, Prague 2, Czech Republic. E-mail: mhalu{at}lf1.cuni.cz.
Chronic peroxisome proliferator-activated receptor (PPAR)-
activation improves glucose metabolism in rodent models of insulin resistance and diabetes; however, PPAR-
deficiency was also reported to protect against high-fat diet (HFD)-induced insulin resistance. The aim of this study was to clarify the role of PPAR-
in the development of insulin resistance using PPAR-
knockout (KO) mice and wild-type controls (WT). Both WT and PPAR-
KO mice on HFD gained significantly more weight relative to chow-fed groups and displayed an increase in insulin levels and a decrease in adiponectin levels. Hyperinsulinemic-euglycemic clamp performed in the nonfasting state demonstrated that HFD caused a marked reduction in whole body, muscle, and white and brown adipose tissue glucose uptake in both WT and PPAR-
KO mice relative to chow-fed groups. Suppression of endogenous glucose production during the clamp was markedly blunted in both WT and PPAR-
KO HFD-fed mice, indicating liver insulin resistance. The magnitude of HFD-induced changes in the clamp parameters of insulin sensitivity was comparable in PPAR-
KO and WT mice. In conclusion, these data show that PPAR-
deficiency does not alter insulin sensitivity in mice fed normal chow diet and does not protect against HFD-induced insulin resistance as measured by hyperinsulinemic-euglycemic clamp in nonfasted state.
This article has been cited by other articles:
![]() |
K. M. Tordjman, C. F. Semenkovich, T. Coleman, R. Yudovich, S. Bak, E. Osher, M. Vechoropoulos, and N. Stern Absence of Peroxisome Proliferator-Activated Receptor-{alpha} Abolishes Hypertension and Attenuates Atherosclerosis in the Tsukuba Hypertensive Mouse Hypertension, November 1, 2007; 50(5): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Noland, J. P. Thyfault, S. T. Henes, B. R. Whitfield, T. L. Woodlief, J. R. Evans, J. A. Lust, S. L. Britton, L. G. Koch, R. W. Dudek, et al. Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E31 - E41. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Knauf, J. Rieusset, M. Foretz, P. D. Cani, M. Uldry, M. Hosokawa, E. Martinez, M. Bringart, A. Waget, S. Kersten, et al. Peroxisome Proliferator-Activated Receptor-{alpha}-Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain Endocrinology, September 1, 2006; 147(9): 4067 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ayala, D. P. Bracy, O. P. McGuinness, and D. H. Wasserman Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse Diabetes, February 1, 2006; 55(2): 390 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Lin, Q. Xu, S. Yeh, R.-S. Wang, J. D. Sparks, and C. Chang Insulin and Leptin Resistance With Hyperleptinemia in Mice Lacking Androgen Receptor Diabetes, June 1, 2005; 54(6): 1717 - 1725. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |